Jazz Pharmaceuticals plc
Ticker: 1232524
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 1.1K-5.1% | 1.1K+7.7% | 1.0K+16.5% | 897.84-14.9% | 1.1K+3.0% | 1.0K+13.5% | 901.98-7.2% | 972.14 |
| Total Income | 1.1K-5.1% | 1.1K+7.7% | 1.0K+16.5% | 897.84-14.9% | 1.1K+3.0% | 1.0K+13.5% | 901.98-7.2% | 972.14 |
| EXPENSES | ||||||||
| Expenditure | 732.30-31.5% | 1.1K-38.3% | 1.7K+81.6% | 953.73+20.0% | 794.76-3.6% | 824.38-1.4% | 835.78+4.5% | 799.75 |
| Tax | 6.10+102.5% | -242.42-1311.9% | -17.17+3.6% | -17.81-22.6% | -14.53+52.6% | -30.65-362.6% | 11.67+124.7% | -47.18 |
| PROFIT | ||||||||
| PBT | 299.20+3209.7% | 9.04+101.2% | -735.55-569.8% | -109.81-154.7% | 200.81+45.6% | 137.93+8720.6% | -1.60-101.6% | 99.52 |
| Net Profit | 293.10+16.6% | 251.41+135.0% | -718.47-676.4% | -92.54-143.0% | 215.06+27.6% | 168.57+1253.0% | -14.62-110.0% | 146.82 |
| KEY METRICS | ||||||||
| OPM % | 31.49%+26.38pp | 5.11%+70.75pp | -65.64%-59.41pp | -6.22%-30.89pp | 24.66%+5.18pp | 19.48%+12.14pp | 7.34%-10.39pp | 17.73% |
| NPM % | 27.42%+5.09pp | 22.33%+91.03pp | -68.71%-58.40pp | -10.31%-30.69pp | 20.39%+3.92pp | 16.46%+18.09pp | -1.62%-16.72pp | 15.10% |
| EPS | 4.73+14.3% | 4.14+135.3% | -11.74-672.4% | -1.52-143.4% | 3.50+30.6% | 2.68+1265.2% | -0.23-109.9% | 2.33 |
Corporate Events
Board MeetingJAZZ
202623Jul
Board Meeting
Annual General Meeting to elect three director nominees, rat…
SEC Filing ↗ Board MeetingJAZZ
202625May
Board Meeting
Director Anne O’Riordan will not stand for re-election at th…
SEC Filing ↗